A carregar...
The Pharmacologic Treatment of Stuttering and Its Neuropharmacologic Basis
Stuttering is a DSM V psychiatric condition for which there are no FDA-approved medications for treatment. A growing body of evidence suggests that dopamine antagonist medications are effective in reducing the severity of stuttering symptoms. Stuttering shares many similarities to Tourette’s Syndrom...
Na minha lista:
| Publicado no: | Front Neurosci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118465/ https://ncbi.nlm.nih.gov/pubmed/32292321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00158 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|